Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 1
1972 9
1973 33
1974 51
1975 90
1976 65
1977 103
1978 55
1979 62
1980 63
1981 45
1982 70
1983 49
1984 54
1985 56
1986 60
1987 54
1988 56
1989 63
1990 59
1991 66
1992 88
1993 97
1994 92
1995 120
1996 109
1997 115
1998 178
1999 158
2000 151
2001 126
2002 131
2003 141
2004 92
2005 94
2006 104
2007 111
2008 84
2009 83
2010 91
2011 68
2012 91
2013 86
2014 104
2015 82
2016 73
2017 72
2018 65
2019 65
2020 55
2021 69
2022 58
2023 47
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

4,111 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
Crisafulli E, Zanini A, Pisi G, Pignatti P, Poli G, Scuri M, Chetta A. Crisafulli E, et al. Expert Rev Respir Med. 2016;10(5):481-90. doi: 10.1586/17476348.2016.1161508. Epub 2016 Mar 16. Expert Rev Respir Med. 2016. PMID: 26938578 Review.
The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique, this influences drug delivery and distribution along the bronchial tree, including the most peripheral airways. The fixed combination of beclometasone dipropionate/f …
The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique, this influences drug delivery an …
Beclometasone oral--DOR BioPharma.
[No authors listed] [No authors listed] Drugs R D. 2007;8(2):91-4. doi: 10.2165/00126839-200708020-00003. Drugs R D. 2007. PMID: 17324006 Review.
orBec is an oral enteric-coated tablet formulation of the corticosteroid beclometasone, which has been developed by Enteron Pharmaceuticals, a subsidiary of Corporate Technology Development (now DOR BioPharma). orBec is being developed for the treatment of gastrointestinal …
orBec is an oral enteric-coated tablet formulation of the corticosteroid beclometasone, which has been developed by Enteron Pharmaceu …
High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
Corradi M, Spinola M, Petruzzelli S, Kuna P. Corradi M, et al. Ther Adv Respir Dis. 2016 Oct;10(5):492-502. doi: 10.1177/1753465816654442. Epub 2016 Jun 23. Ther Adv Respir Dis. 2016. PMID: 27340255 Free PMC article. Review.
The high-strength formulation of extrafine beclometasone dipropionate/formoterol fumarate (BDP/Form) 200/6 g has been developed to step up inhaled corticosteroid treatment, without increasing the dose of the bronchodilator, in patients who are not controlled with previous …
The high-strength formulation of extrafine beclometasone dipropionate/formoterol fumarate (BDP/Form) 200/6 g has been developed to st …
Beclometasone for chronic obstructive pulmonary disease.
De Coster DA, Jones M, Thakrar N. De Coster DA, et al. Cochrane Database Syst Rev. 2013 Oct 9;(10):CD009769. doi: 10.1002/14651858.CD009769.pub2. Cochrane Database Syst Rev. 2013. PMID: 24105424 Review.
OBJECTIVES: To determine the effectiveness and safety in COPD of inhaled beclometasone alone compared with placebo, and of inhaled beclometasone in combination with LABAs compared with LABAs alone. ...AUTHORS' CONCLUSIONS: We found little evidence to suggest that …
OBJECTIVES: To determine the effectiveness and safety in COPD of inhaled beclometasone alone compared with placebo, and of inhaled …
Beclometasone inhaler-induced recovery of refractory peri-ileostomy skin complications.
McDonald M, Connelly TM, Brett A, McCullough P, Cooke F, Neary P. McDonald M, et al. Br J Nurs. 2023 Mar 23;32(6):S16-S26. doi: 10.12968/bjon.2023.32.6.S16. Br J Nurs. 2023. PMID: 36952367
FINDINGS: The cases of one male and one female patient with an end ileostomy post-subtotal colectomy for ulcerative colitis, one female with a defunctioning ileostomy post-anterior resection for sigmoid carcinoma and one male with an end ileostomy with a complex Crohn's surgical …
FINDINGS: The cases of one male and one female patient with an end ileostomy post-subtotal colectomy for ulcerative colitis, one female with …
Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease.
Singh D, Corradi M, Spinola M, Petruzzelli S, Papi A. Singh D, et al. NPJ Prim Care Respir Med. 2016 Jun 16;26:16030. doi: 10.1038/npjpcrm.2016.30. NPJ Prim Care Respir Med. 2016. PMID: 27309985 Free PMC article. Review.
A fixed-dose inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD). ...
A fixed-dose inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and form …
Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
Fabbri LM, Nicolini G, Olivieri D, Papi A. Fabbri LM, et al. Expert Opin Pharmacother. 2008 Feb;9(3):479-90. doi: 10.1517/14656566.9.3.479. Expert Opin Pharmacother. 2008. PMID: 18220498 Review.
OBJECTIVE: To review available data on a recently developed combination of beclometasone dipropionate (BDP) and formoterol (F) given via a pressurized metered-dose inhaler. ...
OBJECTIVE: To review available data on a recently developed combination of beclometasone dipropionate (BDP) and formoterol (F) given …
Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.
Derom E, Pauwels RA. Derom E, et al. Clin Pharmacokinet. 2005;44(8):815-36. doi: 10.2165/00003088-200544080-00004. Clin Pharmacokinet. 2005. PMID: 16029067 Review.
Compared to the reference beclometasone dipropionate formulation, the mass median aerodynamic diameter of the Qvar formulations are substantially smaller (1.1 vs 4.0 microm), whereas that of Modulite averages 2.6 microm. ...Good studies on the bioequivalence between the re …
Compared to the reference beclometasone dipropionate formulation, the mass median aerodynamic diameter of the Qvar formulations are s …
Fluticasone and beclometasone: what are their effects on children's growth?
Saini K, Griffiths P. Saini K, et al. Br J Community Nurs. 2003 May;8(5):221-5. doi: 10.12968/bjcn.2003.8.5.11201. Br J Community Nurs. 2003. PMID: 12746583 Review.
This fear may be reduced with newer agents with lower oral bioavailability if their theoretical advantage of fewer systemic adverse effects than the standard treatment of inhaled beclometasone is realized in practice. This review aims to determine if one of the newer agent …
This fear may be reduced with newer agents with lower oral bioavailability if their theoretical advantage of fewer systemic adverse effects …
4,111 results

Searches related to "beclometasone"